The optimal chemotherapeutic regimen in D2-resected locally advanced gastric cancer: a propensity score-matched analysis

Adjuvant chemotherapy using TS-1 or capecitabine plus oxaliplatin improves survival outcomes after radical gastrectomy, with both regimens showing similar efficacies. A total of 494 patients with stage II‒III gastric cancer who underwent curative D2 gastrectomy and received adjuvant chemotherapy fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Jun Eul, Ki, Myung Seo, Kim, Karham, Jung, Sung-Hoon, Shim, Hyun-Jeong, Bae, Woo-Kyun, Hwang, Eu-Chang, Hur, Young Hoe, Jeong, Oh, Ryu, Seong Yeob, Park, Young Kyu, Cho, Sang-Hee, Lee, Ju-Seog, Chung, Ik-Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630436/
https://www.ncbi.nlm.nih.gov/pubmed/29029536
http://dx.doi.org/10.18632/oncotarget.16301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630436/
https://www.ncbi.nlm.nih.gov/pubmed/29029536
http://dx.doi.org/10.18632/oncotarget.16301

Ejemplares similares